PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary Dysplasia

Recruiting

Phase 1

Phase 2

MontelukastPK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary Dysplasia

Sponsor:

Duke University

Code:

NCT07101640

Conditions

Bronchopulmonary Dysplasia (BPD)

Premature Births

Critical Illness

Eligibility Criteria

Sex: All

Age: 0

Healthy Volunteers: Not accepted

Interventions

montelukast 4 mg granule

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-04-19. This information was provided to ClinicalTrials.gov by Duke University on 2026-03-06.